Opportunity Information: Apply for CDC RFA GH13 13010501SUPP18
This grant opportunity, titled "Program Expansion Supplement to Cooperative Agreement on Immunization with the World Health Organization (WHO)," is a CDC-issued supplemental funding action designed to extend the timeline of an existing cooperative agreement rather than launch a broad, open competition. The supplement supports continuation of work tied to major US Government-endorsed global immunization priorities, specifically the Global Polio Eradication Initiative, the Global Measles Initiative, and the Global Immunization Vision and Strategy (2006-2015). In practical terms, the intent is to ensure that critical immunization and disease control activities already underway through WHO can keep operating without disruption while broader global eradication, elimination, and disease reduction targets are pursued.
The core activities emphasized in the description focus on strengthening the systems needed to detect, confirm, and stop vaccine-preventable diseases (VPDs), with polio and measles highlighted as central priorities. This includes supporting surveillance for polio, measles, and other VPDs so countries can rapidly identify suspected cases, investigate outbreaks, and monitor progress toward elimination. It also includes maintaining and enhancing the global laboratory networks that provide diagnostic confirmation and standardized testing capacity for polio and measles, which is essential for credible surveillance and for verifying whether transmission has been interrupted. Another major component is support for planning and implementing supplemental immunization activities, such as targeted or mass vaccination campaigns that close immunity gaps, respond to outbreaks, or accelerate progress in hard-to-reach populations. The opportunity also stresses strengthening routine immunization delivery systems in developing countries, meaning improvements in the everyday capacity of health systems to deliver vaccines reliably, manage cold chain and logistics, track coverage, and build workforce and program management capabilities.
The opportunity explicitly frames these activities as critical to globally agreed goals around eradication, elimination, and reduction of disease burden. Beyond polio and measles, the notice leaves room for the cooperative agreement to support additional global health priorities that align with CDC goals, indicating flexibility to apply resources to related immunization and infectious disease needs as circumstances evolve. It is also linked to "Healthy People 2020" focus areas, particularly Immunization and Infectious Disease and Maternal, Infant and Child Health, reflecting the broader public health rationale that improving vaccination systems and controlling infectious diseases directly benefits child survival and community health outcomes.
Administratively, this is a discretionary funding opportunity using a cooperative agreement mechanism, which typically indicates substantial programmatic involvement by the funding agency (CDC) in planning, coordination, or oversight compared to a standard grant. The opportunity is cataloged under CFDA 93.185 and is managed by the Centers for Disease Control and Prevention, Center for Global Health (CDC-CGH). Only one award is expected, and eligibility is limited exclusively to the World Health Organization; no other applicants are being solicited, making it a single-entity, continuation-style supplement rather than a competitive call. The listing notes an original closing date of October 14, 2017, and identifies the opportunity number as CDC RFA GH13-13010501SUPP18. The award ceiling is listed as 0, which commonly signals that the maximum amount is not specified in the public synopsis or is determined through internal budgeting for the supplement rather than advertised as a fixed cap.Apply for CDC RFA GH13 13010501SUPP18
- The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Program Expansion Supplement to Cooperative Agreement on Immunization with the World Health Organization (WHO)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185.
- This funding opportunity was created on 2017-08-14.
- Applicants must submit their applications by 2017-10-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Program Expansion Supplement to Cooperative Agreement on Immunization with the World Health Organization (WHO)."
Who is issuing this funding opportunity?
This is a CDC-issued supplemental funding action managed by the Centers for Disease Control and Prevention (CDC), Center for Global Health (CDC-CGH).
What type of funding action is this?
It is a discretionary supplemental funding action under a cooperative agreement mechanism.
Is this a new competitive grant program?
No. The description indicates this supplement is meant to extend the timeline of an existing cooperative agreement and continue work already underway, rather than start a broad, open competition.
What is the cooperative agreement mechanism, and what does it imply?
A cooperative agreement typically means the funding agency (CDC) has substantial programmatic involvement in the work, such as participation in planning, coordination, or oversight, compared with a standard grant.
What is the purpose of this supplement?
The intent is to ensure critical immunization and disease control activities already being conducted through WHO can continue without disruption while global eradication, elimination, and disease reduction targets are pursued.
Which global immunization priorities are specifically referenced?
The opportunity is tied to major US Government-endorsed global immunization priorities, including:
- The Global Polio Eradication Initiative
- The Global Measles Initiative
- The Global Immunization Vision and Strategy (2006-2015)
Which diseases are emphasized as central priorities?
Polio and measles are highlighted as central priorities, within a broader focus on vaccine-preventable diseases (VPDs).
What kinds of surveillance activities are supported?
The opportunity emphasizes strengthening systems needed to detect, confirm, and stop VPDs. This includes surveillance for polio, measles, and other VPDs to help countries rapidly identify suspected cases, investigate outbreaks, and monitor progress toward elimination.
Does the opportunity include laboratory support?
Yes. A major component is maintaining and enhancing global laboratory networks that provide diagnostic confirmation and standardized testing capacity for polio and measles, supporting credible surveillance and verification of whether transmission has been interrupted.
What are "supplemental immunization activities" in this context?
They include targeted or mass vaccination campaigns intended to close immunity gaps, respond to outbreaks, or accelerate progress in hard-to-reach populations.
Is routine immunization strengthening part of the scope?
Yes. The opportunity stresses strengthening routine immunization delivery systems in developing countries, including improvements in day-to-day capacity to deliver vaccines reliably, manage cold chain and logistics, track coverage, and strengthen workforce and program management.
Are activities limited only to polio and measles?
No. While polio and measles are central priorities, the notice indicates flexibility to support additional global health priorities aligned with CDC goals as circumstances evolve.
How does this opportunity relate to broader public health goals?
It is framed as critical to globally agreed goals around eradication, elimination, and reduction of disease burden, and it is linked to Healthy People 2020 focus areas, particularly Immunization and Infectious Disease and Maternal, Infant and Child Health.
What is the CFDA number for this opportunity?
The listing is cataloged under CFDA 93.185.
What is the opportunity number?
The opportunity number is CDC RFA GH13-13010501SUPP18.
Who is eligible to apply?
Eligibility is limited exclusively to the World Health Organization (WHO). No other applicants are being solicited.
How many awards are expected?
Only one award is expected.
Is the funding amount (maximum award) specified?
The award ceiling is listed as 0, which commonly indicates the maximum amount is not specified in the public synopsis or is determined internally for the supplement rather than published as a fixed cap.
What is the closing date listed for this opportunity?
The listing notes an original closing date of October 14, 2017.
Is this opportunity intended to prevent disruption of ongoing work?
Yes. The description explicitly states the intent is to keep critical activities already underway through WHO operating without disruption.
What are examples of system improvements mentioned for routine immunization?
Examples named include improving reliable vaccine delivery, managing cold chain and logistics, tracking coverage, and building workforce and program management capabilities.
Why are laboratory networks described as essential in this opportunity?
They are described as essential for diagnostic confirmation and standardized testing capacity, which supports credible surveillance and helps verify whether disease transmission has been interrupted (particularly for polio and measles).
Browse more opportunities from the same category: Health
Next opportunity: Farm Business Management and Benchmarking Competitive Grants Program
Previous opportunity: BLM-CO Motorized Trail Program, Royal Gorge Field Office
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 13010501SUPP18
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 13010501SUPP18) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Public Health Laboratory, Workforce Development, and Health Systems Research Capacity of the Cambodian National Institute of Public Health under the GHSA and PEPFAR Apply for CDC RFA GH18 1820 Funding Number: CDC RFA GH18 1820 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $650,000 |
| Partnering with the Ministry of Health of Vietnam to Build a Sustainable System for HIV/AIDS Prevention, Care, and Treatment in the Socialist Republic of Vietnam under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 130405CONT18 Funding Number: CDC RFA GH13 130405CONT18 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Clinical and Public Health Curriculum Development, Training, and Information Systems Support for the Haitian Health Care System under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH18 1834 Funding Number: CDC RFA GH18 1834 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $2,425,500 |
| Zero Suicide Initiative Apply for HHS 2018 IHS ZSI 0001 Funding Number: HHS 2018 IHS ZSI 0001 Agency: Indian Health Service Category: Health Funding Amount: $400,000 |
| Strengthening the Coordination of HIV/AIDS Response at National and Subnational Levels in Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH18 1809 Funding Number: CDC RFA GH18 1809 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $380,000 |
| Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM-PHACTS) under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 16150301SUPP17 Funding Number: CDC RFA GH15 16150301SUPP17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $2,969,692 |
| Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation Apply for CDC RFA CK20 2001 Funding Number: CDC RFA CK20 2001 Agency: Centers for Disease Control - NCEZID Category: Health Funding Amount: $100,000 |
| USAID/Uganda Local Service Delivery for HIV/AIDS Activity Apply for 72061720RFA00002 Funding Number: 72061720RFA00002 Agency: Uganda USAID-Kampala Category: Health Funding Amount: $50,000,000 |
| NIA Research Centers Collaborative Network (RCCN) (U24 Clinical Trial Optional) Apply for RFA AG 21 001 Funding Number: RFA AG 21 001 Agency: National Institutes of Health Category: Health Funding Amount: $675,000 |
| Drug-Free Communities (DFC) Support Program – Non-competing Continuation Apply for CDC RFA CE20 2004 Funding Number: CDC RFA CE20 2004 Agency: Centers for Disease Control - NCIPC Category: Health Funding Amount: $125,000 |
| Using Syndemics to Understand HLBS Disease Emergence and Progression in People with HIV (PWH)(R01 Clinical Trial Not Allowed) Apply for RFA HL 21 018 Funding Number: RFA HL 21 018 Agency: National Institutes of Health Category: Health Funding Amount: $485,000 |
| PEPFAR Grants for Community-Led Monitoring Apply for DOS NG PEPFARCLM FY2022 001 Funding Number: DOS NG PEPFARCLM FY2022 001 Agency: U.S. Mission to Nigeria Category: Health Funding Amount: $25,000 |
| Life Course Translational Research Network (LCT-RN) Apply for HRSA 23 083 Funding Number: HRSA 23 083 Agency: Health Resources and Services Administration Category: Health Funding Amount: $800,000 |
| Advancing Health Equity in Asthma Control through EXHALE Strategies Apply for CDC RFA EH 24 0016 Funding Number: CDC RFA EH 24 0016 Agency: Centers for Disease Control - NCEH Category: Health Funding Amount: $725,000 |
| Children, Adolescents, and Families in the HIV Epidemic in North West Province Apply for 72067423RFA00012 Funding Number: 72067423RFA00012 Agency: South Africa USAID-Pretoria Category: Health Funding Amount: $20,000,000 |
| Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) Apply for CDC RFA CK 24 0002 Funding Number: CDC RFA CK 24 0002 Agency: Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Implementation of Community Health Worker-Mediated Services for Re-Engagement to Care and Outreach for Persons with HIV in Rural Communities (REACH: Rural Re-Engagement and Care using CHWs for Persons with HIV) Apply for CDC RFA PS 24 0026 Funding Number: CDC RFA PS 24 0026 Agency: Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Epidemiologic Cohort Study of Interstitial Cystitis Apply for RFA DP 24 031 Funding Number: RFA DP 24 031 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $900,000 |
| Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings Apply for RFA DP 24 081 Funding Number: RFA DP 24 081 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $950,000 |
| Native Hawaiian Health Care Improvement Act Program Apply for HRSA 24 030 Funding Number: HRSA 24 030 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 13010501SUPP18", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.